Ketogenic Diet for ALS
Also known as: Keto diet, LCHF, Metabolic therapy
Ketogenic diet may support ALS motor neurons through alternative energy supply and anti-inflammatory effects, though high caloric needs in ALS require careful management.
Mechanism of Action
ALS motor neurons face energy crisis from mitochondrial dysfunction. BHB provides direct mitochondrial fuel through acetyl-CoA generation without requiring Complex I (which may be impaired). Anti-inflammatory effects (NF-κB, NLRP3 suppression) may reduce neuroinflammatory motor neuron damage.
General mechanism: High-fat, very-low-carbohydrate diet inducing ketosis. BHB serves as alternative fuel, HDAC inhibitor, AMPK activator, anti-inflammatory agent.
Current Evidence
Feasibility studies show ketogenic diet is achievable in ALS patients with careful nutritional support. High caloric intake is essential in ALS (weight loss worsens prognosis), which makes standard ketogenic diets challenging. Modified high-calorie ketogenic protocols are being developed.
Clinical Status: Feasibility studies for ALS. Caloric management is critical. Modified protocols under development.
Safety Profile
Generally safe with medical supervision. Kidney stone risk, lipid profile changes, nutritional deficiencies without supplementation. Contraindicated in fatty acid oxidation disorders.
Key Research Questions
- Can high-calorie ketogenic diet maintain weight while providing metabolic neuroprotection?
- Does BHB directly protect motor neurons from excitotoxicity?
Frequently Asked Questions
Does the ketogenic diet help with cancer?
The ketogenic diet exploits the Warburg effect — cancer cells' dependence on glucose. Clinical trials in glioblastoma show safety and metabolic benefits as adjunctive therapy. It may enhance chemotherapy and radiation effectiveness. It's studied as complementary, not replacement, therapy.
Ketogenic diet for Alzheimer's prevention
Alzheimer's involves impaired brain glucose metabolism (sometimes called 'type 3 diabetes'). Ketones provide an alternative brain fuel. The modified Mediterranean-ketogenic diet (MMKD) trial showed improved CSF Alzheimer's biomarkers. Most promising for MCI and early-stage prevention.